The Role of Inflammasomes in LPS and Gram-Negative Bacterial Sepsis
Journal of Clinical Medicine · 09.10.2025 · 14 (19) · 7102
DOI: 10.3390/jcm14197102 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.10.2025. Verfasst von Eduardo Hernández-Cuellar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biología Celular y Tisular, Departamento de Morfología, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, CP, Mexico. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Autónoma de Aguascalientes.
Themen: Sepsis
Abstract (Originalsprache)
Background/Objectives: Sepsis is a life-threatening condition characterized by an uncontrolled immune response due to systemic infections. It is responsible for millions of deaths worldwide. Although inflammasomes play an important role in host defense, they have a detrimental role in sepsis induced by LPS or Gram-negative bacteria. We aimed to revise the molecular mechanisms of inflammasome activation in sepsis by LPS and Gram-negative bacteria other than cytokine release as treatments blocking TNF-α and IL-1 cytokines have been ineffective even though cytokine storm is associated with lethality.
Results
Studies with knockout mice deficient in inflammasome-derived cytokines have shown contrasting results on the role of these proinflammatory cytokines in the lethality of LPS- and Gram-negative-induced sepsis. However, DAMPs released after non-canonical inflammasome activation such as extracellular DNA, histones, HMGB1, and tissue factor result in disseminated-intravascular coagulation (DIC) and mortality in mice. Blocking these products in preclinical studies with animal models showed improved clinical scores and survival after LPS-induced sepsis or polymicrobial sepsis induced by Cecal Ligation and Puncture.
Conclusions
Even though immunomodulatory drugs have shown inconclusive results as therapies for sepsis, blocking DAMPs associated with DIC may be considered for clinical trials in the future, especially in patients presenting biomarkers of coagulopathies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Biología Celular y Tisular, Departamento de Morfología, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, CP, Mexico.
- Division of Immunology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.
- Epidemiology, Endocrinology & Nutrition Research Unit, Hospital Infantil de México Federico Gómez, Mexico City 06720, CP, Mexico.
- Research Division, Faculty of Medicine, Universidad Nacional Autónoma de México (UNAM), Mexico City 04360, CP, Mexico.
- Laboratory of Translational Research in Cellular and Molecular Biology, Hospital Infantil de México Federico Gómez, Mexico City 06720, CP, Mexico.
ORCID-Profile: Eduardo Hernández-Cuellar, Oscar Medina-Contreras
Förderung
- Universidad Autónoma de Aguascalientes
Zitieren
APA
Hernández-Cuellar, E., Tsuchiya, K., Medina-Contreras, O., & Valle-Ríos, R. (2025). The Role of Inflammasomes in LPS and Gram-Negative Bacterial Sepsis. Journal of Clinical Medicine, 14(19), 7102. https://doi.org/10.3390/jcm14197102
Vancouver
Hernández-Cuellar E, Tsuchiya K, Medina-Contreras O, Valle-Ríos R. The Role of Inflammasomes in LPS and Gram-Negative Bacterial Sepsis. Journal of Clinical Medicine. 2025;14(19):7102. doi:10.3390/jcm14197102
BibTeX
@article{HernndezCuellar2025,
author = {Hernández-Cuellar, Eduardo and Tsuchiya, Kohsuke and Medina-Contreras, Oscar and Valle-Ríos, Ricardo},
title = {The Role of Inflammasomes in LPS and Gram-Negative Bacterial Sepsis},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {19},
pages = {7102},
doi = {10.3390/jcm14197102}
}
EUVIMED